ID 263480337 © Viniciussouza06 | Dreamstime.com
dreamstime_xxl_263480337
Infectious Disease

Rapid increase in Oropouche virus in Western hemisphere

Nov. 20, 2024
Health officials warn that the vector-borne illness has potential for sexual transmission.
ID 330744468 © Wutianzeri | Dreamstime.com
dreamstime_xxl_330744468
ID 202506718 © Dzmitry Skazau | Dreamstime.com
dreamstime_xxl_202506718
ID 174325726 © Jarun011 | Dreamstime.com
dreamstime_xxl_174325726
ID 328614437 © Michalsuszycki | Dreamstime.com
dreamstime_xxl_328614437
Infectious Disease

Transforming diagnostics in GI infections: The role of molecular testing

To take the test online go HERE. For more information, visit the Continuing Education tab. LEARNING OBJECTIVES Upon completion of this article, the reader will be able to: 1. ...
ID 202769125 © Geargodz | Dreamstime.com
dreamstime_xxl_202769125
Infectious Disease

COVID-19 study reveals virus-induced inflammation during pregnancy, redefines vertical transmission

Oct. 18, 2024
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
Courtesy of the NIH
20241016mpoxvirus
Infectious Disease

Mpox vaccine is safe and generates a robust antibody response in adolescents

Oct. 18, 2024
NIH clinical trial addresses knowledge gap on vaccine use in adolescent populations.
ID 254532862 © Yuri Arcurs | Dreamstime.com
dreamstime_xxl_254532862
Infectious Disease

New national survey shows hesitancy about vaccines this fall

Sept. 25, 2024
37% of poll respondents say they feel they don’t need to be vaccinated.
Courtesy of NIAID, NIH
Colorized transmission electron micrograph of mpox virus particles (blue) cultivated and purified from cell culture. NIAID.
Infectious Disease

NIH releases mpox research agenda

Sept. 18, 2024
Plan will advance knowledge of virus biology to improve detection, treatment and prevention.
ID 330748461 © Wutianzeri | Dreamstime.com
dreamstime_xxl_330748461
Infectious Disease

WHO and partners establish an access and allocation mechanism for mpox vaccines, treatments, tests

Sept. 16, 2024
This is part of the response to the public health emergency of international concern declared by WHO Director-General Dr Tedros Adhanom Ghebreyesus on August 14 2024, following...
ID 177520808 © Thanasate Chancherngrob | Dreamstime.com
dreamstime_xxl_177520808
Infectious Disease

1 in 5 COVID deaths potentially attributable to hospital caseload strain

Sept. 10, 2024
According to the authors, this is the first study to examine the effect of hospital type and infrastructure on the care quality for COVID-19 amid caseload stress.
Courtesy of the CDC
26502
ID 197617498 © Feverpitched | Dreamstime.com
dreamstime_xxl_197617498
Infectious Disease

FDA authorizes updated Novavax COVID-19 vaccine to better protect against currently circulating variants

Sept. 3, 2024
This authorization follows the FDA’s recent approvals and authorizations of updated mRNA COVID-19 vaccines for 2024-2025 manufactured by ModernaTX Inc. and Pfizer Inc.
ID 330807969 © Tobias Arhelger | Dreamstime.com
dreamstime_xxl_330807969
Infectious Disease

WHO urges rapid access to mpox diagnostic tests, invites manufacturers to emergency review

Aug. 30, 2024
Testing is key for people to get treatment and care as early as possible and prevent further spread.